26 April 2018: Sysmex to Launch JICA Project in the Republic of Ghana – “Collaboration Program for Disseminating Automated Urinalysis Diagnosis Technology”
25 April 2018: Sysmex Obtains Certification under ISO Guide 34, the International Standard for the Competence of Reference Material Producers
08 April 2018: Sysmex launches Caresphere,™ a new network solution supporting the intelligent use of information for the healthcare of the future

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) offers a new network solution, Caresphere,™ to provide new value through the intelligent use of information by people involved in testing and healthcare, with a view to accelerating the future use of information in healthcare. Caresphere™ creates an environment for linking and analyzing a variety of information from testing instruments and laboratory information systems1 in real time, seamlessly and safely in one platform. Through Caresphere,™ Sysmex will support the resolution from a new dimension of issues faced by customers around the world.

20 February 2018: Sysmex Celebrates Its 50th Anniversary

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) celebrated the 50th anniversary of its establishment on February 20, 2018. We offer our heartfelt appreciation for the support of our customers and all other stakeholders since the time of our establishment in 1968.

20 February 2018: FY2017 Nakatani Award and Research Grant Recipients Announced

The Tokyo-based Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering announced 2 recipients of The Nakatani Award, 38 recipients of its Technology Development Research Grants and 2 recipients of its Investigative Research Grants for fiscal 2017.

20 December 2017: Australasia’s premier histopathology event a resounding success

The National Histology Conference was a collaborative endeavour this year as hosts Histology Group of Victoria worked together with histology groups from Queensland, New South Wales and South Australia to create a true national conference. Held in Hobart, Tasmania, it is the first instance of the conference being held in a state without an organised […]

16 October 2017: Commencement of Collaborative Research on Measurement of Exosomes in Blood from Cancer Patients

The National Cancer Center Japan, JVCKENWOOD Corporation, Sysmex Corporation and Daiichi Sankyo Company Limited announced today that they have commenced collaborative research with the aim of raising the quality of cancer diagnosis and treatment. The collaborative research will target exosome, a microparticle released from tissues.

13 September 2017: Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Second Consecutive Year

The Dow Jones Sustainability Indexes are developed through collaboration between S&P Dow Jones Indices of the United States and Robeco SAM, a Swiss research specialist in the area of socially responsible investment. This year Sysmex has been selected for inclusion in the DJSI World for the second consecutive year.

10 August 2017: Sysmex, Hyogo Pharmaceutical Society and Shinkai Transport Systems Enter Agreement to Cooperate on Disaster Relief Activities

Creating a System for Operating Mobile Pharmacies as a Disaster Response Measure – Sysmex Corporation, the Hyogo Pharmaceutical Society and Shinkai Transport Systems, Ltd. announce the signing of an agreement to cooperate on disaster relief activities, aimed at operating mobile pharmacies in times of disaster.

01 June 2017: Sysmex Opens New R&D Facility with a View toward the Realisation of Personalised Medicine

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has opened a new R&D facility within its Kawasaki Innovation Gateway at SKYFRONT in the city of Kawasaki, Kanagawa Prefecture, to pursue R&D in bioinformatics, a key technology toward the realisation of personalised medicine.